FDA Inspection 1174389 — Oxford Pharmaceuticals, LLC
The FDA completed an inspection of Oxford Pharmaceuticals, LLC on June 8, 2022 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 8, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Birmingham, AL (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)